Chemoinformaics analysis of 1,11-TRIDECADIENE-3,5,7,9-TETRAYNE
| Molecular Weight | 164.207 | nRot | 0 |
| Heavy Atom Molecular Weight | 156.143 | nRig | 6 |
| Exact Molecular Weight | 164.063 | nRing | 0 |
| Solubility: LogS | -4.909 | nHRing | 0 |
| Solubility: LogP | 4.807 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.0443 |
| nHD | 0 | BPOL | 8.02566 |
| QED | 0.478 |
| Synth | 4.484 |
| Natural Product Likeliness | 2.432 |
| NR-PPAR-gamma | 0.891 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.68 |
| CACO-2 | -4.124 |
| MDCK | 0.000139802 |
| BBB | 0 |
| PPB | 1.04188 |
| VDSS | 1.309 |
| FU | 0.0278483 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.141 |
| CYP2c19-inh | 0.908 |
| CYP2c19-sub | 0.659 |
| CYP2c9-inh | 0.869 |
| CYP2c9-sub | 0.921 |
| CYP2d6-inh | 0.694 |
| CYP2d6-sub | 0.434 |
| CYP3a4-inh | 0.857 |
| CYP3a4-sub | 0.289 |
| CL | 6.968 |
| T12 | 0.126 |
| hERG | 0 |
| Ames | 0.489 |
| ROA | 0.858 |
| SkinSen | 0.982 |
| Carcinogencity | 0.453 |
| EI | 0.99 |
| Respiratory | 0.738 |
| NR-Aromatase | 0.968 |
| Antiviral | No |
| Prediction | 0.694038 |